Cutaneous reactions to azacitidine.

Suppr

超能文献

作者信息

Goldsmith S M, Sherertz E F, Powell B L, Hurd D D

出版信息

Arch Dermatol. 1991 Dec;127(12):1847-8.

PMID:1726972

Abstract

摘要

相似文献

Cutaneous reactions to azacitidine.

Arch Dermatol. 1991 Dec;127(12):1847-8.

Azacitidine: a new medication associated with Sweet syndrome.

J Am Acad Dermatol. 2011 May;64(5):e77-9. doi: 10.1016/j.jaad.2010.06.032.

Case of azacitidine-induced maculopapular erythematous eruption.

J Dermatol. 2013 Aug;40(8):680-1. doi: 10.1111/1346-8138.12181. Epub 2013 Jun 5.

Treatment of refractory adult acute nonlymphoblastic leukemia with subcutaneous 5-azacytidine.

Cancer Treat Rep. 1977 Dec;61(9):1721-3.

Severe cutaneous reaction following measles immunization.

Int J Dermatol. 2009 Aug;48(8):873-4. doi: 10.1111/j.1365-4632.2009.04108.x.

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension.

Oncologist. 2005 Mar;10(3):176-82. doi: 10.1634/theoncologist.10-3-176.

[Calciparin hypersensitivity reaction].

Ann Dermatol Venereol. 1993;120(11):845-6.

Tolerability of Vidaza (azacitidine) subcutaneous administration using a maximum volume of 3 ml per injection.

J Oncol Pharm Pract. 2016 Aug;22(4):605-10. doi: 10.1177/1078155215598854. Epub 2015 Aug 5.

Cutaneous reactions associated with vitamin K1.

J Cutan Med Surg. 2000 Jul;4(3):164-8.

Tricotropism by pentazocine.

Arch Dermatol. 1987 Mar;123(3):297-8.

引用本文的文献

Azacitidine-induced bullous pemphigoid-like localized toxic reaction.

Einstein (Sao Paulo). 2025 Mar 3;23:eRC0699. doi: 10.31744/einstein_journal/2025RC0699. eCollection 2025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cutaneous reactions to azacitidine.

Arch Dermatol. 1991 Dec;127(12):1847-8.

Azacitidine: a new medication associated with Sweet syndrome.

J Am Acad Dermatol. 2011 May;64(5):e77-9. doi: 10.1016/j.jaad.2010.06.032.

Case of azacitidine-induced maculopapular erythematous eruption.

J Dermatol. 2013 Aug;40(8):680-1. doi: 10.1111/1346-8138.12181. Epub 2013 Jun 5.

Treatment of refractory adult acute nonlymphoblastic leukemia with subcutaneous 5-azacytidine.

Cancer Treat Rep. 1977 Dec;61(9):1721-3.

Severe cutaneous reaction following measles immunization.

Int J Dermatol. 2009 Aug;48(8):873-4. doi: 10.1111/j.1365-4632.2009.04108.x.

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension.

Oncologist. 2005 Mar;10(3):176-82. doi: 10.1634/theoncologist.10-3-176.

[Calciparin hypersensitivity reaction].

Ann Dermatol Venereol. 1993;120(11):845-6.

Tolerability of Vidaza (azacitidine) subcutaneous administration using a maximum volume of 3 ml per injection.

J Oncol Pharm Pract. 2016 Aug;22(4):605-10. doi: 10.1177/1078155215598854. Epub 2015 Aug 5.

Cutaneous reactions associated with vitamin K1.

J Cutan Med Surg. 2000 Jul;4(3):164-8.

Tricotropism by pentazocine.

Arch Dermatol. 1987 Mar;123(3):297-8.

引用本文的文献

Azacitidine-induced bullous pemphigoid-like localized toxic reaction.

Einstein (Sao Paulo). 2025 Mar 3;23:eRC0699. doi: 10.31744/einstein_journal/2025RC0699. eCollection 2025.